Shilpa Medicare Limited — Board Meeting, 26-05-2025: Outcome of Board Meeting

Shilpa Medicare has announced a board meeting to approve the financial results for the quarter and half-year. For FY25, consolidated revenue rose to ₹1,309.57 Cr with net profit doubling to ₹78.29 Cr from last year. A ₹29 Cr provision was made for a legal settlement with Celltrion Inc. The board proposed a final dividend of Re. 1 per share. VV.J. Talati & Co and BDO India LLP have been appointed as Cost and Internal Auditors for FY26. Shilpa Biologicals Pvt Ltd is now a material subsidiary starting FY26.